Futibatinib as a bridge to transplantation and post-transplant maintenance in blast-phase MLN-ZMYM2::FGFR1

Tino Vollmer, Christoph Schell, Milena Pantic, Dietmar Pfeifer, Robert Zeiser, Khalid Shoumariyeh

Open source

DOI
10.1186/s13045-026-01866-8
Published
2026-11-02
Container
Journal of Hematology & Oncology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13045-026-01866-8,
  title = {Futibatinib as a bridge to transplantation and post-transplant maintenance in blast-phase MLN-ZMYM2::FGFR1},
  author = {Tino Vollmer and Christoph Schell and Milena Pantic and Dietmar Pfeifer and Robert Zeiser and Khalid Shoumariyeh},
  year = {2026},
  journal = {Journal of Hematology \& Oncology},
  doi = {10.1186/s13045-026-01866-8},
  url = {https://doi.org/10.1186/s13045-026-01866-8}
}

RIS

TY  - JOUR
TI  - Futibatinib as a bridge to transplantation and post-transplant maintenance in blast-phase MLN-ZMYM2::FGFR1
AU  - Tino Vollmer
AU  - Christoph Schell
AU  - Milena Pantic
AU  - Dietmar Pfeifer
AU  - Robert Zeiser
AU  - Khalid Shoumariyeh
PY  - 2026
JO  - Journal of Hematology & Oncology
DO  - 10.1186/s13045-026-01866-8
UR  - https://doi.org/10.1186/s13045-026-01866-8
ER  - 

APA

Vollmer, T., Schell, C., Pantic, M., Pfeifer, D., Zeiser, R., & Shoumariyeh, K. (2026). Futibatinib as a bridge to transplantation and post-transplant maintenance in blast-phase MLN-ZMYM2::FGFR1. Journal of Hematology & Oncology. https://doi.org/10.1186/s13045-026-01866-8

Source records